Replimune (REPL) EBIT (2017 - 2026)
Replimune (REPL) recorded EBIT of -$68.25 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$90.42 million a year earlier.
Powered by 
Analysis
Replimune (REPL) EBIT (2017 - 2026) Analysis & Trends
On a TTM basis, Replimune's EBIT came in at -$297.74 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$319.92 million.
- Across earlier fiscal years, EBIT came in at -$261.63 million in FY2025, -$234.77 million in FY2024, -$177.08 million in FY2023 and -$118.31 million in FY2022.
- The fiscal Q1 2027 figure is the highest quarterly EBIT since fiscal Q3 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$73.34 million (Q4 2026), -$71.87 million (Q3 2026) and -$84.29 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.42 Bn | 1,106.00 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.98 Bn | 536.51 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 502.80 Bn | 475.92 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 368.67 Bn | 323.05 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.36 Bn | 262.35 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.17 Bn | 234.85 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.18 Bn | 192.58 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.11 Bn | 165.31 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Replimune | 1.13 Bn | 74.38 Mn | - | -68.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -68.25 Mn |
| Mar 31, 2026 | -73.34 Mn |
| Dec 31, 2025 | -71.87 Mn |
| Sep 30, 2025 | -84.29 Mn |
| Jun 30, 2025 | -90.42 Mn |
| Mar 31, 2025 | -79.33 Mn |
| Dec 31, 2024 | -66.02 Mn |
| Sep 30, 2024 | -58.92 Mn |
| Jun 30, 2024 | -57.37 Mn |
| Mar 31, 2024 | -58.76 Mn |
| Dec 31, 2023 | -56.54 Mn |
| Sep 30, 2023 | -63.83 Mn |
| Jun 30, 2023 | -55.65 Mn |
| Mar 31, 2023 | -53.00 Mn |
| Dec 31, 2022 | -41.63 Mn |
| Sep 30, 2022 | -41.58 Mn |
| Jun 30, 2022 | -40.88 Mn |
| Mar 31, 2022 | -31.99 Mn |
| Dec 31, 2021 | -29.70 Mn |
| Sep 30, 2021 | -29.25 Mn |
API Access
Replimune EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();